Mesenchymal stromal cells treatment attenuates dry eye in patients with chronic graft-versus-host disease.
about
Control of Cross Talk between Angiogenesis and Inflammation by Mesenchymal Stem Cells for the Treatment of Ocular Surface DiseasesMesenchymal stem cells for treating ocular surface diseasesHuman mesenchymal stem cells (MSCs) for treatment towards immune- and inflammation-mediated diseases: review of current clinical trialsMesenchymal stem cells for treating autoimmune dacryoadenitisThird-party mesenchymal stem cells improved human islet transplantation in a humanized diabetic mouse modelAllogeneic Mesenchymal Stem Cell Transplantation in Dogs With Keratoconjunctivitis Sicca.Adult human mesenchymal stromal cells and the treatment of graft versus host disease.Remestemcel-L for acute graft-versus-host disease therapy.Adult adherent stromal cells in the management of graft-versus-host disease.Efficacy of immunotherapy with mesenchymal stem cells in man: a systematic review.Current and Upcoming Therapies for Ocular Surface Chemical Injuries.Development of Causative Treatment Strategies for Lacrimal Gland Insufficiency by Tissue Engineering and Cell Therapy. Part 1: Regeneration of Lacrimal Gland Tissue: Can We Stimulate Lacrimal Gland Renewal In Vivo?Bone marrow-derived mesenchymal stem cells (JR-031) for steroid-refractory grade III or IV acute graft-versus-host disease: a phase II/III study.Amniotic membrane mesenchymal cells-derived factors skew T cell polarization toward Treg and downregulate Th1 and Th17 cells subsets.Regenerative Therapies in Dry Eye Disease: From Growth Factors to Cell Therapy.CD8+CD28- T cells: not only age-related cells but a subset of regulatory T cells.The Use of Human Mesenchymal Stem Cells as Therapeutic Agents for the Treatment of Immune-Related Diseases: A Systematic Review
P2860
Q26750660-A1AC063D-8861-4DEC-B880-58D8207138B2Q28071279-04DDA26D-3959-4C60-8693-7A444FF28D8DQ28071916-CBB8FCD8-3A47-4919-853D-76839BCFF3C5Q33768081-117BC322-A6E2-4065-9E82-B5F80FE1133EQ37181396-C20659C3-1E68-471C-B140-E52C689165BBQ37513322-8A5C34F8-FD95-46B3-8CA7-72A011BD7E03Q37622055-C93395AB-159C-4E4F-9462-D6905AAD62CEQ38172271-E57A4788-8661-4CDF-AB9E-01A46E5EE56DQ38176442-2BB04859-56FA-49D0-AC06-C6AC29BCA136Q38393820-FB4F9531-BA3A-4AE0-A723-FFF0061D10D3Q38819339-A46F90B2-23D9-4336-8658-EA3C8C29CE69Q38875664-928FC18F-F92B-44F1-A525-7DD77BB6B084Q40273820-C9D49462-692E-456B-A9E0-0B6A43858C08Q41518676-F9D9C411-B630-4AC8-8006-756986FB5DFDQ47138584-604B0088-44F5-4B5A-8913-0E3984379D1CQ49634132-94781E82-EB66-40D8-8B1D-5A11E68C95C3Q57538743-FE9D0239-8C4E-4363-B485-D53F6E505771
P2860
Mesenchymal stromal cells treatment attenuates dry eye in patients with chronic graft-versus-host disease.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Mesenchymal stromal cells trea ...... nic graft-versus-host disease.
@ast
Mesenchymal stromal cells trea ...... nic graft-versus-host disease.
@en
type
label
Mesenchymal stromal cells trea ...... nic graft-versus-host disease.
@ast
Mesenchymal stromal cells trea ...... nic graft-versus-host disease.
@en
prefLabel
Mesenchymal stromal cells trea ...... nic graft-versus-host disease.
@ast
Mesenchymal stromal cells trea ...... nic graft-versus-host disease.
@en
P2093
P2860
P356
P1433
P1476
Mesenchymal stromal cells trea ...... nic graft-versus-host disease.
@en
P2093
Andy Xiangpeng
Chenwei Luo
Jianyu Weng
Peilong Lai
Suijing Wu
Suxia Geng
Xialin Liu
P2860
P304
P356
10.1038/MT.2012.208
P577
2012-10-16T00:00:00Z